In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Clinical Trials Innovation

The Acorn Saga Continues

Executive Summary

Acorn Cardiovascular and Paracor Medical are frequently compared with one another because they are taking similar approaches to treating heart failure. Acorn has gone through a series of setbacks that have slowed its product development, but it's hoping that this third time is the charm. The company reached agreement with the FDA to embark on a 50-patient clinical trial that Acorn hopes leads to agency clearance of its CorCap device. (This is a sidebar to the article, "Paracor: Can a Mechanical Device Treat Heart Failure?")

Table

View full table

Topics

Tags:
Medical Device Clinical Trials Innovation
Latest Headlines

Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics

Fujifilm Demonstrates Health Specialism With European HealthTech Spinout

Financing Quarterly Statistics, Q1 2024

Helping Organizations Deliver On KPIs And Giving Staff A Voice

See All
UsernamePublicRestriction

Register

IV002873

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By